+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Study of knowledge of genital herpes infection and attitudes to testing for genital herpes among antenatal clinic attendees

Study of knowledge of genital herpes infection and attitudes to testing for genital herpes among antenatal clinic attendees

Australian & New Zealand Journal of Obstetrics & Gynaecology 43(5): 351-353

A descriptive survey of knowledge of genital herpes and attitudes to testing was conducted among antenatal clinic attendees at the Gold Coast Hospital, Australia. The study subjects showed a good knowledge of genital herpes, to a level that appears sufficient for an informed choice regarding herpes serology testing to be made. A preference for testing for genital herpes was suggested. Although serological testing is not routinely required, the results of the study indicate that discussion of genital herpes should be considered in the antenatal clinic setting.

(PDF emailed within 1 workday: $29.90)

Accession: 050427853

Download citation: RISBibTeXText

PMID: 14717310

Related references

Knowledge of genital herpes infection among antenatal clinic attendees in South-Eastern Nigeria. East African Medical Journal 86(7): 344-347, 2010

Antenatal serum screening for genital herpes: A study of knowledge and attitudes of women at a central London hospital. British Journal of Obstetrics and Gynaecology 104(3): 347-349, 1997

A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes. Developments in Biological Standardization 52: 95-98, 1982

Trends in genital herpes simplex virus infections among San Francisco STD clinic attendees, 1995-1999. Clinical Infectious Diseases 31(1): 305, July, 2000

Comparative epidemiology of clinically-apparent genital herpes among sexually transmitted disease clinic attendees. Clinical Infectious Diseases 31(1): 305, July, 2000

Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. Journal of Infectious Diseases 167(4): 942-946, 1993

Demographic, behavioral, and knowledge factors associated with herpes simplex virus type 2 infection among men whose current female partner has genital herpes. Sexually Transmitted Diseases 32(5): 308-313, 2005

Is suspicion of genital herpes infection associated with avoiding sex? A clinic-based study. Sexual Health 5(3): 279-283, 2008

Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK. Sexually Transmitted Infections 79(1): 35-41, 2003

The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London. Sexually Transmitted Infections 81(4): 306-308, 2005

Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Archives of Internal Medicine 157(3): 343-349, 1997

Genital herpes in a sexually-transmitted infection clinic in Singapore: a 1-year retrospective study. Annals of the Academy of Medicine, Singapore 33(2): 200-203, 2004

In search of optimal genital herpes management and standard of care (INSIGHTS): doctors' and patients' perceptions of genital herpes. Sexually Transmitted Infections 84(1): 51-56, 2007

Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. Journal of Medical Virology 73(4): 601-604, 2004

Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes. Antiviral Chemistry & ChemoTherapy 23(5): 189-196, 2015